In RA-FLS, expression of p53 was suppressed by cytokines, including IL-1β, TNF-α and IL-17, leading to subsequent stimulation of IL-6 production by activating the NF-κB and MAPK pathways. The gene discussed is IL17A; the disease is rheumatoid arthritis.